ArticleHealth care science2024
SkinSage XAI: An explainable deep learning solution for skin lesion diagnosis.
Article in Health care science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Interpretable Skin Cancer Identification Using a Hybrid Deep Learning and XAI Framework on HAM10000.Bioengineering (Basel, Switzerland) · 2026Article
- CBAM-Xception: An Attention-Guided Framework for Skin Cancer Classification.Journal of imaging informatics in medicine · 2026Article
- SkinSage XAI: An explainable deep learning solution for skin lesion diagnosis.Health care science · 2024Article
- Explainable AI-driven hybrid deep learning framework for accurate skin cancer diagnosis.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Skin cancer poses a significant global health threat, with early detection being essential for successful treatment. While deep learning algorithms have greatly enhanced the categorization of skin lesions, the black-box nature of many models limits interpretability, posing challenges for dermatologists. Methods: To address these limitations, SkinSage XAI utilizes advanced explainable artificial intelligence (XAI) techniques for skin lesion categorization. A data set of around 50,000 images from the Customized HAM10000, selected for diversity, serves as the foundation. The Inception v3 model is used for classification, supported by gradient-weighted class activation mapping and local interpretable model-agnostic explanations algorithms, which provide clear visual explanations for model outputs. Results: SkinSage XAI demonstrated high performance, accurately categorizing seven types of skin lesions-dermatofibroma, benign keratosis, melanocytic nevus, vascular lesion, actinic keratosis, basal cell carcinoma, and melanoma. It achieved an accuracy of 96%, with precision at 96.42%, recall at 96.28%, Conclusions: SkinSage XAI represents a significant advancement in dermatology and artificial intelligence by bridging gaps in accuracy and explainability. The system provides transparent, accurate diagnoses, improving decision-making for dermatologists and potentially enhancing patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.